GGrantIndex
Sort

53,477 grants matching addiction

Brain Imaging of Human Drug Abuse

$1,121,388
Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2012 · DA

EPPIC-Net Pain Research - Application for Clinical Trial and Related Activities (OT2)

$1,121,347
Maurizio Fava · Massachusetts General Hospital · OT2 · FY2025 · NS

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$1,121,304
James L. Sorensen · University Of California, San Francisco · U10 · FY2012 · DA

Neurometabolomics and Neuroproteomics Center on Cell-Cell Signaling

$1,121,287
Jonathan V. Sweedler · University Of Illinois At Urbana-Champaign · P30 · FY2025 · DA

Structure and Function of Neurotransmitter Transporters

$1,120,940
Harel Weinstein · Weill Medical Coll Of Cornell Univ · P01 · FY2014 · DA

Anesthetic-Eluting Contact Lens for Corneal Pain

$1,120,889
Joseph B. Ciolino · Schepens Eye Research Institute · UG3 · FY2023 · NS

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$1,120,441
James L. Sorensen · University Of California, San Francisco · U10 · FY2013 · DA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$1,120,441
James L. Sorensen · University Of California, San Francisco · U10 · FY2014 · DA

Sex Differences and Progesterone Effects on Impulsivity, Smoking & Cocaine Abuse

$1,120,279
Marilyn E. Carroll · University Of Minnesota · P50 · FY2012 · DA

Control Of Behavior By Drug Injections

$1,120,084
Steven Goldberg · National Institute On Drug Abuse · ZIA · FY2014 · DA

Novel interventions to reduce stress induced non-homeostatic eating

$1,119,898
Elissa S. Epel · University Of California, San Francisco · U01 · FY2011 · HL

Novel imaging of endplate biomarkers in chronic low back pain

$1,119,116
Aaron J Fields · University Of California, San Francisco · UH2 · FY2019 · AR

Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy

$1,118,712
Debra Kimless · Pure Green Pharmaceuticals, Inc. · R44 · FY2023 · DK

Center for Study of Opioid Receptors and Drugs of Abuse

$1,117,954
University Of California Los Angeles · P50 · FY2002 · DA

Control of the time course of dopamine release through optimized electrical brain stimulation.

$1,117,585
Stephen Leigh Cowen · University Of Arizona · R01 · FY2021 · NS

Clinical Trials Network: Pacific Northwest Node

$1,117,527
Dennis M Donovan · University Of Washington · U10 · FY2012 · DA

Corticostriatal mechanisms of action learning and habit formation

$1,117,058
David M Lovinger · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA

Interacting Signaling Pathways that Initiate Squamous Cell Carcinogenesis

$1,116,803
Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

NIDA Clinical Trials Network: Greater New York Node

$1,116,411
John P Rotrosen · New York University School Of Medicine · UG1 · FY2015 · DA

Discovery and/or Validation of Pharmacodynamic Markers

$1,116,392
Sulayman D Dib-Hajj · Marine Biological Laboratory · U19 · FY2021 · NS

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors

$1,116,367
Eun-Ok Im · University Of Texas At Austin · R33 · FY2024 · CA

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors

$1,116,366
Eun-Ok Im · University Of Texas At Austin · R33 · FY2025 · CA

21/24 Healthy Brain and Child Development National Consortium

$1,116,118
Douglas Carl Dean III · University Of Wisconsin-Madison · U01 · FY2022 · DA

Pharmacology and toxicology of newly-emerging designer drugs of abuse

$1,115,953
Michael Baumann · National Institute On Drug Abuse · ZIA · FY2017 · DA

Preventing Substance Use in the Context of Poverty: Risk and Protection from Early Childhood to Early Adulthood

$1,115,408
Daniel S Shaw · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DA